BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17466000)

  • 1. Radioiodine treatment for benign thyroid diseases.
    Weetman AP
    Clin Endocrinol (Oxf); 2007 Jun; 66(6):757-64. PubMed ID: 17466000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioiodine therapy of euthyroid multinodular goitres.
    Manders JM; Corstens FH
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S466-70. PubMed ID: 12192547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
    Bonnema SJ; Hegedüs L
    Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Graves' hyperthyroidism--prognostic factors for outcome.
    Alfadda A; Malabu UH; El-Desouki MI; Al-Rubeaan KA; Al-Ruhaily AD; Fouda MA; Al-Maatouq MA; Sulimani RA
    Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma.
    Salvatori M; Luster M
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):821-8. PubMed ID: 20186542
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of radioiodine therapy on urinary iodine excretion.
    Meller B; Lauer I; Bähre M; Richter E
    Nuklearmedizin; 1998 May; 37(3):107-12. PubMed ID: 9604231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of thyrotoxicosis in children and adolescents: 35 years' experience in 304 patients.
    Azizi F; Amouzegar A
    J Pediatr Endocrinol Metab; 2018 Jan; 31(2):159-165. PubMed ID: 29306930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional autonomies of thyroid and efficacy of radioiodine therapy.
    Kraft O; Stepien A
    Cancer Biother Radiopharm; 2007 Apr; 22(2):261-7. PubMed ID: 17600474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy and Graves' ophthalmopathy.
    Sisson JC; Schipper MJ; Nelson CC; Freitas JE; Frueh BR
    J Nucl Med; 2008 Jun; 49(6):923-30. PubMed ID: 18483104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
    Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
    Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is long-term methimazole therapy as effective as radioiodine for treating hyperthyroidism?
    Toft AD
    Nat Clin Pract Endocrinol Metab; 2005 Nov; 1(1):14-5. PubMed ID: 16929359
    [No Abstract]   [Full Text] [Related]  

  • 16. [Radioiodine therapy of benign thyroid disease in Denmark].
    Rasmussen AK; Jarløv AE; Faber J
    Ugeskr Laeger; 2000 Jan; 162(3):327-30. PubMed ID: 10680467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stunning in radioiodine therapy of benign thyroid disease. Quantification and therapeutic relevance].
    Krohn T; Meyer PT; Ocklenburg C; Knollmann D; Nowak B; Schaefer WM
    Nuklearmedizin; 2008; 47(6):248-54. PubMed ID: 19057798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mortality in hyperthyroidism during periods of treatment with thionamides and after radioiodine.
    Boelaert K; Maisonneuve P; Torlinska B; Franklyn JA
    J Clin Endocrinol Metab; 2013 May; 98(5):1869-82. PubMed ID: 23543662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.
    Fast S; Bonnema SJ; Hegedüs L
    Ann Endocrinol (Paris); 2011 Apr; 72(2):129-35. PubMed ID: 21513911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodine treatment for malignant thyroid disease.
    Berg G
    Acta Oncol; 2006; 45(8):1041-5. PubMed ID: 17118836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.